Net Income

In a move securing benefits for 400 retirees, Laurentian Bank transfers pension duties, reflecting a wider industry trend to reduce risk and simplify.

Surging NYC energy bills have homeowners facing a tough choice. Learn the key signs that your aging HVAC system needs replacement, not another costly repair.

Ocugen heads to a top investor conference with a bold plan for its gene-agnostic therapy, aiming to treat blindness and secure its future in a crowded market.

The institutional crypto exchange reported a sharp decline in spot trading for December, but a massive surge in options volume points to a maturing market.

ChipMOS reports stunning 20.8% Q4 growth, highlighting a memory chip frenzy fueled by AI and datacenters. Is this the start of a new tech supercycle?

From a $2.3B real estate privatization to blockbuster retail earnings and a shifting job market, key corporate moves reveal a nation at a crossroads.

With support from a bipartisan alliance, nonprofit newsroom Votebeat is scaling up its expert reporting to fight election misinformation and bolster trust.

Crypto exchange HTX reveals 39% growth in its 2025 report, but the real story is its strategic pivot to tech, compliance, and long-term value.

With dual robotic arms and AI radar, Dreame's award-winning X-Wind AC offers personalized airflow, signaling a new era for intelligent home technology.

Kezar Life Sciences faces a critical FDA meeting for its novel liver disease drug, a decision that could bring hope to patients and define the company's future.

At CES 2026, Chinese startup KunlunMeta and AMD launched a portable AI terminal, promising unprecedented mobile productivity and data privacy.

Pandora's 2025 growth slows amid weak consumer sentiment, but a new CEO plans a strategic reset to combat rising costs and boost brand desirability.

Sanuwave Health posts record revenue, defying industry-wide turmoil as reimbursement cuts reshape the advanced wound care market. How did they do it?

The semiconductor giant's stellar revenue, driven by a 19% surge in its core packaging business, confirms strong demand for AI and advanced tech.

A new AI-designed vaccine, TG4050, has prevented relapse in all head and neck cancer patients in a key trial, signaling a breakthrough in personalized medicine.

AS Tallinna Sadam reports robust 2025 results, with a major jump in liquid bulk cargo and a strong rebound in cruise tourism signaling regional recovery.

As Valneva meets investors, all eyes are on its pivotal Lyme disease vaccine data, a potential game-changer for public health and the company's future.

Ventyx Biosciences is under investigation for misleading investors after a trial delay caused a 15% stock drop, even as a pharma giant moves to acquire it.

Boston's Moody Aldrich Partners commits $600M to London's SCIO Capital, a major validation of specialized asset-backed lending in Europe's booming market.

The P&C insurance tech leader leverages its strong cash position for a massive buyback, signaling confidence amid its successful cloud transformation.